stoxline Quote Chart Rank Option Currency Glossary
  
Surmodics, Inc. (SRDX)
35.1  0.72 (2.09%)    05-28 16:00
Open: 34.18
High: 35.38
Volume: 42,751
  
Pre. Close: 34.38
Low: 34.18
Market Cap: 501(M)
Technical analysis
2024-05-28 4:56:13 PM
Short term     
Mid term     
Targets 6-month :  41.84 1-year :  48.88
Resists First :  35.83 Second :  41.84
Pivot price 33.63
Supports First :  29.24 Second :  25.17
MAs MA(5) :  34.77 MA(20) :  33.15
MA(100) :  31.01 MA(250) :  31.72
MACD MACD :  1.6 Signal :  1.5
%K %D K(14,3) :  73.9 D(3) :  77.2
RSI RSI(14): 66.9
52-week High :  39.4 Low :  17.79
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ SRDX ] has closed below upper band by 20.8%. Bollinger Bands are 3.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 35.43 - 35.57 35.57 - 35.71
Low: 33.83 - 33.98 33.98 - 34.13
Close: 34.85 - 35.09 35.09 - 35.33
Company Description

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Headline News

Sat, 25 May 2024
Surmodics, Inc. (NASDAQ:SRDX) to Post Q3 2024 Earnings of ($0.31) Per Share, Zacks Research Forecasts - Defense World

Fri, 24 May 2024
Surmodics, Inc. (NASDAQ:SRDX) to Post Q3 2024 Earnings of ($0.31) Per Share, Zacks Research Forecasts - MarketBeat

Fri, 24 May 2024
Surmodics, Inc. (NASDAQ:SRDX) Expected to Post FY2026 Earnings of $0.32 Per Share - Defense World

Thu, 23 May 2024
SurModics (SRDX) Down 22.1% Since Last Earnings Report: Can It Rebound? - Yahoo Singapore News

Thu, 23 May 2024
Analysts Issue Forecasts for Surmodics, Inc.'s FY2026 Earnings (NASDAQ:SRDX) - MarketBeat

Tue, 21 May 2024
Surmodics, Inc.'s (NASDAQ:SRDX) Intrinsic Value Is Potentially 96% Above Its Share Price - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 14 (M)
Shares Float 11 (M)
Held by Insiders 3.7 (%)
Held by Institutions 91.7 (%)
Shares Short 496 (K)
Shares Short P.Month 447 (K)
Stock Financials
EPS 0.95
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 8.68
Profit Margin 9.4 %
Operating Margin 2 %
Return on Assets (ttm) 6.6 %
Return on Equity (ttm) 11.9 %
Qtrly Rev. Growth 17.5 %
Gross Profit (p.s.) 0
Sales Per Share 10.02
EBITDA (p.s.) 1.9
Qtrly Earnings Growth 0 %
Operating Cash Flow 26 (M)
Levered Free Cash Flow 22 (M)
Stock Valuations
PE Ratio 36.56
PEG Ratio -5.9
Price to Book value 4.03
Price to Sales 3.5
Price to Cash Flow 19.43
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android